Physician profile
Paul Chang
NPI 1285639740
$2,454.50
in general payments reported to CMS, 2019-2025
15 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $71.12 · 2021: $183 · 2022: $107 · 2023: $110 · 2024: $108 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819 · Travel and Lodging: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.80 |
| Travel and Lodging | $436.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,840.34 | 2019-2025 | Pangea, Triathlon, Mako |
| Davol INC. | $136.51 | 2021 | |
| Heron Therapeutics, INC. | $119.45 | 2022-2024 | Zynrelef |
| Wright Medical Technology, INC. | $55.22 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $52.99 | 2025 | |
| Smith+Nephew, INC. | $33.84 | 2022-2024 | Evos |
| Fidia Pharma USA INC. | $33.60 | 2020-2024 | Hymovis, Hyalgan, Triluron |
| Next Science LLC | $29.22 | 2023 | Surgx, Blastx, Xperience |
| Acumed LLC | $29.08 | 2024 | Nanophix Implant |
| Pacira Pharmaceuticals Incorporated | $25.98 | 2019 | |
| Bioventus LLC | $24.88 | 2021 | |
| Endo Pharmaceuticals INC. | $22.02 | 2021 | |
| Ferring Pharmaceuticals INC. | $19.40 | 2023 | Euflexxa |
| Pacira Therapeutics, INC. | $16.58 | 2019 | |
| Molnlycke Health Care US, LLC | $15.39 | 2024 | Mepilex Border Post-Op Ag, Avance, Mepilex Border Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.